Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and gemcitabine in resected pancreatic cancer
NCT02005419Phase 2Completed
- Sponsor
- Xian-Jun Yu
- Start
- Dec 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in pancreatic adenocarcinoma (PDAC), sponsored by Xian-Jun Yu. Started Dec 2013; status: completed.
02
Drugs
metformin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02005419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005419.